Cypris Medical Announces Commercial Launch of Xact Device

CHICAGO--(BUSINESS WIRE)-- Cypris Medical, Inc., a company committed to improving outcomes by making plastic surgery less invasive, announced today the commercial release of its Xact device for minimally invasive face and neck lift suturing.

“I’m excited that Cypris Medical is the first to effectively address a sizable unmet need in facial aesthetics,” said Dan Holton, Chief Executive Officer. “The first application of our Xact technology is designed to provide surgical outcomes of gravitational descent in the face and neck via a minimally invasive procedure. The device has already developed a strong patient satisfaction track record. It’s a favorable solution for the millions of patients who need more than neurotoxins and fillers, but don't want to undergo a full face or neck lift.” He added, “The technology is the first of its kind in plastic surgery and is being extended to additional applications currently under development. We are incredibly proud to spearhead a new generation of minimally invasive plastic surgery.”

The Xact suturing device achieved FDA clearance in April 2017. The commercial launch follows a successful evaluation period in which patients demonstrated satisfying, lasting results over two years. Procedures that use Xact are well suited to be performed without general anesthesia in out-patient settings. Procedures can be completed in less than an hour. Patients typically recover in five days or less. Comparatively, traditional facelift, browlift and necklift surgical treatments require general anesthesia and longer recovery time.

“Minimally invasive options are becoming the standard in surgical procedures throughout medicine. It’s time for plastic surgery to advance, and the Xact device is well equipped to pioneer that shift,” said Dr. Louis Bucky, a board-certified plastic surgeon, who serves on the Cypris Medical Advisory Board.

“Xact technology will absolutely transform our industry’s treatment of facial aging,” said Dr. Christopher Godek, a board-certified plastic surgeon and lead clinical investigator for Xact. “This innovation can replace previous technologies, such as thread lifts, which have proven ineffective due to imprecise anatomic targets, limited longevity and high complication rates including thread extrusion. The Xact device effectively extends a surgeon’s hands into hard-to-reach areas. Utilizing small, two-centimeter-long incisions hidden within the hairline, surgeons can accurately and precisely lift, reposition and suture tissue.”

Xact is a hand-held surgical suturing device designed to approximate and pass

suture through soft tissue. Xact extends a surgeon’s hands allowing them to place sutures precisely with less tissue disruption. This makes procedures that use Xact less invasive which speeds recovery time. Xact can be used in any procedure that requires precise delivery of a suture.

About Cypris Medical

Headquartered in Chicago, IL, Cypris Medical is committed to improving outcomes by making plastic surgery less invasive. The aesthetics market is growing rapidly, and to continue to meet the needs of patients, minimally invasive treatments that provide results comparable to surgery will be needed. Cypris Medical is uniquely qualified to deliver minimally invasive solutions to the market by leveraging more than 100 years combined experience in medical devices and plastic surgery.

For more information, visit https://cyprismed.com/ and on Instagram @cyprismedical.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190723005311/en/